$5.32
0.234.52%
Ult. Agg.: Sep 30, 7:41 PM
$5.30
0.214.13%
AN2 Therapeutics (ANTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.23 | $-0.24 | $-0.22 |
| Actual | $-0.18 | $-0.29 | $-0.29 | $-0.31 |
| Surprise | +25.0% | -26.1% | -20.8% | -40.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.20 | $-0.23 |
| Revenue | ||
| Consensus | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.18 | $-0.24 | 25.0 % |
| Q1 | May 11, 2026 | $-0.29 | $-0.23 | -26.1 % |
| Q4 | Mar 17, 2026 | $-0.29 | $-0.24 | -20.8 % |
| Q3 | Nov 12, 2025 | $-0.31 | $-0.22 | -40.9 % |